P-0054 Carbon Nanoparticles Mapping Sentinel Node in Patients with T1-3 Gastric Cancer

نویسندگان
چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Sentinel node mapping for gastric cancer.

BACKGROUND Sentinel lymph node mapping is the standard of care for patients with malignant melanoma and breast cancer. Recently, SLN mapping was introduced to the field of gastric cancer. OBJECTIVES To evaluate SLN mapping in patients with gastric cancer. METHODS In 43 patients with gastric cancer, open intraoperative subserosal dye injection in four opposing peritumoral points was used. Te...

متن کامل

Sentinel Lymph Node Mapping In Gastric Cancer Surgery: Current Status

Lymphonodular metastases remain an important predictive and prognostic factor in gastric cancer development. The precise determination of the lymphonodular invasion stage can be made only by extended intraoperative lymphadenectomy and histopathological examination. But the main controversy is the usefulness of extended lymph dissection in early gastric cancer. This increases the duration of the...

متن کامل

Sentinel node navigation surgery in patients with early gastric cancer.

Clinical application of sentinel node (SN) mapping in patients with early gastric cancer has been a controversial issue for years. However, a recent meta-analysis and a prospective multicenter trial of SN mapping for early gastric cancer have shown acceptable SN detection rates and accuracy of determination of lymph node status. A dual-tracer method that utilizes radioactive colloids and blue d...

متن کامل

[Sentinel lymph node mapping in patients with colorectal cancer].

UNLABELLED The colorectal cancer is the most frequent and clinically significant tumor of the gastrointestinal tract. For more than 100 years, radical lymphadenectomy has been the diagnostic and therapeutic gold standard for the management of metastatic nodal disease. More than 50% of patients are initially present with I and II stage of the disease. About 15% to 30% of these patients develop r...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Annals of Oncology

سال: 2012

ISSN: 0923-7534

DOI: 10.1016/s0923-7534(20)30261-1